NO996540L - Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo - Google Patents

Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo

Info

Publication number
NO996540L
NO996540L NO996540A NO996540A NO996540L NO 996540 L NO996540 L NO 996540L NO 996540 A NO996540 A NO 996540A NO 996540 A NO996540 A NO 996540A NO 996540 L NO996540 L NO 996540L
Authority
NO
Norway
Prior art keywords
nucleic acid
cells
transfer
acid vectors
vivo
Prior art date
Application number
NO996540A
Other languages
English (en)
Norwegian (no)
Other versions
NO996540D0 (no
Inventor
Michel Bureau
Lluis Mir
Daniel Scherman
Bertrand Schwartz
Original Assignee
Rhone Poulenc Rorer Sa
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9708232A external-priority patent/FR2765241B1/fr
Priority claimed from FR9708233A external-priority patent/FR2765242B1/fr
Application filed by Rhone Poulenc Rorer Sa, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Rhone Poulenc Rorer Sa
Publication of NO996540D0 publication Critical patent/NO996540D0/no
Publication of NO996540L publication Critical patent/NO996540L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO996540A 1997-06-30 1999-12-29 Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo NO996540L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9708232A FR2765241B1 (fr) 1997-06-30 1997-06-30 Amelioration du transfert d'acide nucleique dans les cellules d'organismes eucaryotes pluricellulaires et combinaison permettant la mise en oeuvre du procede
FR9708233A FR2765242B1 (fr) 1997-06-30 1997-06-30 Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
US6748797P 1997-12-01 1997-12-01
US6748897P 1997-12-01 1997-12-01
US8385898P 1998-05-01 1998-05-01
PCT/EP1998/003976 WO1999001175A1 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Publications (2)

Publication Number Publication Date
NO996540D0 NO996540D0 (no) 1999-12-29
NO996540L true NO996540L (no) 2000-02-03

Family

ID=27515625

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996540A NO996540L (no) 1997-06-30 1999-12-29 Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo

Country Status (11)

Country Link
EP (1) EP0993318A1 (ko)
JP (1) JP2002515816A (ko)
KR (1) KR20010014298A (ko)
CN (1) CN1261812A (ko)
AU (1) AU8730798A (ko)
BR (1) BR9810500A (ko)
CA (1) CA2295029A1 (ko)
IL (1) IL133709A0 (ko)
NO (1) NO996540L (ko)
PL (1) PL337617A1 (ko)
WO (1) WO1999001175A1 (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
AU2868200A (en) * 1999-02-08 2000-08-25 Chiron Corporation Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
CA2402530C (en) 2000-03-13 2014-01-14 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with cd99
AU5345901A (en) 2000-04-13 2001-10-30 Univ Rockefeller Enhancement of antibody-mediated immune responses
AU2001264759B2 (en) 2000-05-22 2006-06-01 Merck & Co., Inc. System and method for assessing the performance of a pharmaceutical agent delivery system
AU2002227450B2 (en) 2000-12-28 2008-02-28 Wyeth Recombinant protective protein from $I(streptococcus pneumoniae)
CA2441476A1 (en) 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
US20020198567A1 (en) * 2001-06-07 2002-12-26 Yona Keisari Electro-endocytotic therapy as a treatment modality of cancer
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
AU2003230601A1 (en) 2002-03-07 2003-09-22 Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Clinical syringe with electrical stimulation aspects
NZ571508A (en) 2002-05-24 2010-05-28 Schering Corp Neutralizing human anti-IGFR antibody
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1759714A1 (en) * 2005-09-02 2007-03-07 Bioalliance Pharma Electrotransfer of nucleic acid into tissue cells
EP3804809B1 (en) * 2005-10-03 2023-12-27 Novocure GmbH Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
JP4961137B2 (ja) * 2005-12-14 2012-06-27 久光製薬株式会社 イオントフォレーシス用デバイス
AU2007319604B2 (en) 2006-10-19 2011-03-24 Csl Limited High affinity antibody antagonists of interleukin-13 receptor alpha 1
WO2008060814A2 (en) 2006-10-19 2008-05-22 Merck & Co., Inc. ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
US8246176B2 (en) 2007-03-06 2012-08-21 Sanyo Electric Co., Ltd. Projection display device having an operation section for displacing a lens
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
CN102124102B (zh) * 2008-07-18 2013-12-18 麦克赛特股份有限公司 优化电穿孔的方法
EP2356135B1 (en) 2008-11-05 2017-10-25 Wyeth LLC Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
HUE052850T2 (hu) 2010-08-23 2021-05-28 Wyeth Llc Neisseria meningitidis RLP2086 antigéneket tartalmazó stabil készítmények
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
KR101763625B1 (ko) 2012-03-09 2017-08-01 화이자 인코포레이티드 수막염균 조성물 및 이의 사용 방법
WO2014107739A1 (en) 2013-01-07 2014-07-10 Eleven Biotherapeutics, Inc. Antibodies against pcsk9
ES2685894T3 (es) 2013-03-08 2018-10-15 Pfizer Inc. Polipéptidos de fusión inmunogénicos
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
EP3270959A1 (en) 2015-02-19 2018-01-24 Pfizer Inc Neisseria meningitidis compositions and methods thereof
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317380D0 (en) * 1993-08-20 1993-10-06 Therexsys Ltd Transfection process
US5641680A (en) * 1994-11-14 1997-06-24 Zhao; Xi Gene transfer apparatus and method for using the same
WO1997007826A1 (en) * 1995-08-29 1997-03-06 Cbr Laboratories, Inc. In vivo electroporation of cells

Also Published As

Publication number Publication date
CN1261812A (zh) 2000-08-02
IL133709A0 (en) 2001-04-30
EP0993318A1 (en) 2000-04-19
JP2002515816A (ja) 2002-05-28
BR9810500A (pt) 2000-09-05
PL337617A1 (en) 2000-08-28
KR20010014298A (ko) 2001-02-26
CA2295029A1 (en) 1999-01-14
WO1999001175A1 (en) 1999-01-14
NO996540D0 (no) 1999-12-29
AU8730798A (en) 1999-01-25

Similar Documents

Publication Publication Date Title
NO996540L (no) Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo
NO996541L (no) Forbedret metode for overfoering av nukleinsyre til celler i multicellulaere, eukaryotiske organismersamt kombinasjon for dette
NO884457D0 (no) Rektangulaer elektrokjemisk cellegenerator med hjoerneoppvarming.
WO2004021927A3 (en) Cardiac harness
PL337583A1 (en) Improved method of transferring nucleic acid to a striated muscle and connection enabling accomplishment of this method
DE69625935D1 (de) Biomedizinische elektrode mit dielektrischen verlusteigenschaften
DE69902724T2 (de) Auf Energieübertragung gegründetes homogenes lumineszierendes Testverfahren
ES8706422A1 (es) Aparato para transferir selectivamente energia electrica a y desde posiciones criticas en un tejido vivo para realizar diagnostico
DE69827420D1 (de) Herzschrittmacher mit variabler Stimulationsenergie
DK0515667T3 (da) Hydratiserbar iontoforetisk bioelektrode og fremgagsmåde til fremstilling af denne
WO2006010837A3 (fr) Dispositif our le transfert de molecules aux cellules utilisant une force electrique
DE69919983D1 (de) System zum einleiten von herzkammerflimmern unter verwendung von nahfeldwellenabtastung
AU2249701A (en) Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
DE69524481D1 (de) Defibrillator mit mehreren verschiedenartigen Stecker-/Elektroden-Anordnungen
TR199802648A3 (tr) Gen tedavisi için nüklein asit yapilari.
CA2330309A1 (en) Electric therapeutic device
DK0843731T3 (da) Adenovirusvektorer til genterapi
DE19781819T1 (de) Kardiale Schrittmacher-Anschlußvorrichtung
ATE341639T1 (de) Adenovirus-vermittelte gentherapie
DE69737062D1 (de) Gentherapie für kongestives herzversagen
DE964931T1 (de) Testverfahren, das auf der bildung von ringförmigen nukleinsäuren basiert
FI971275A0 (fi) Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset
IT1202021B (it) Forno elettrico autonomo, per usi domestici, con vano di cottura controllato, in particolare, da termoregolatore in correlazione diretta
WO1997031679A3 (en) Biological electrostimulator of viscera
DK0744021T3 (da) Referenceelektrode til galvaniske celler med en ionledende faststofelektrolyt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application